2012
DOI: 10.1586/erm.11.98
|View full text |Cite
|
Sign up to set email alerts
|

Development of chip-compatible sample preparation for diagnosis of infectious diseases

Abstract: Diagnosis of infectious diseases in primary care is predominantly based on medical history and physical examination, as conventional laboratory investigations are often associated with delays that are unacceptable in medical practice. Point-of-care testing, and especially lab-on-a-chip (LoC) systems, are expected to result in a considerable reduction in associated healthcare costs and lead to fast, but appropriate and effective, personalized therapy. Although appropriate sample preparation is essential for fin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
31
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(31 citation statements)
references
References 116 publications
0
31
0
Order By: Relevance
“…Products such as InstaGene Matrix (Bio-Rad) also remove PCR inhibitors from patient samples but dilute the DNA instead of concentrating it. Self-contained microfluidic devices embedded with silica beads or posts have been developed for one-step nucleic acid extractions [15]. However, the small diameter of microfluidic channels restricts the silica surface area available for biomarker adsorption as well as the maximum sample volume that can be flowed through the channels (typically <500 µL) [14].…”
Section: Introductionmentioning
confidence: 99%
“…Products such as InstaGene Matrix (Bio-Rad) also remove PCR inhibitors from patient samples but dilute the DNA instead of concentrating it. Self-contained microfluidic devices embedded with silica beads or posts have been developed for one-step nucleic acid extractions [15]. However, the small diameter of microfluidic channels restricts the silica surface area available for biomarker adsorption as well as the maximum sample volume that can be flowed through the channels (typically <500 µL) [14].…”
Section: Introductionmentioning
confidence: 99%
“…The system should be able to detect pathogens and host biomarkers (proteins and nucleic acids) simultaneously. Sample preparation remains the largest bottleneck in miniaturised diagnostics: 134 large volumes (several millilitres of blood) need to be reduced to small amounts (in the order of microlitres); the microbial load in the sample can vary a lot and be very low; the target should remain intact, but many complex specimens contain nucleases or inhibitors of nucleic acid amplifi cations. Therefore, most sample preparations of available miniaturised molecular systems rely on many operations, and need several liquid additions and washing steps.…”
Section: Huge Technical Challengesmentioning
confidence: 99%
“…The strengths of such systems include a reduced requirement for samples and reagents, fast and high-throughput results, low power consumption, a reduced contamination risk and a high degree of parallelization [1,3]. These designs take advantage of the great developments occurring in microfabrication techniques.…”
Section: Lab-on-a-chip (Loc)mentioning
confidence: 99%
“…New diagnostic tools are needed to meet the increasing demand for fast, reliable and cost-effective diagnostic devices. These new tools would replace currently available tests that can only be conducted in fully equipped diagnostics laboratories [1]. Many research groups have proposed models for POC systems that are implemented in microfluidic-based platforms, based on a wide range of available technologies.…”
Section: Introductionmentioning
confidence: 99%